Realities, Expectations and Attitudes to Life Support Technologies in Intensive Care for Octogenarians: (Realistic 80)

This study has been completed.
Sponsor:
Collaborator:
Canadian Institutes of Health Research (CIHR)
Information provided by (Responsible Party):
Daren K. Heyland, Clinical Evaluation Research Unit at Kingston General Hospital
ClinicalTrials.gov Identifier:
NCT01293708
First received: February 10, 2011
Last updated: February 19, 2013
Last verified: February 2013
  Purpose

The purpose of this study is to understand the realities, expectations and attitudes of patients 80+ and their families about the use of life-sustaining technology, and to document the patient outcomes and family experiences associated with surviving and not surviving critical illness. Specifically in this project the investigators will determine the real outcomes of critical illness experienced by octogenarians.


Condition
Critically Ill

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Realities, Expectations and Attitudes to Life Support Technologies in Intensive Care for Octogenarians:

Further study details as provided by Clinical Evaluation Research Unit at Kingston General Hospital:

Primary Outcome Measures:
  • Health Related Quality of Life (HRQOL) [ Time Frame: 12 months ] [ Designated as safety issue: No ]
    To determine the 12 month HRQOL of 80+ year olds admitted to the ICU in Canada.


Secondary Outcome Measures:
  • To determine which patient characteristics are associated with 12-month HRQOL [ Time Frame: 12 month ] [ Designated as safety issue: No ]
  • To determine which patient characteristics are associated with functional status. [ Time Frame: 12 months ] [ Designated as safety issue: No ]
  • To determine which patient characteristics are associated with survival [ Time Frame: 12 months ] [ Designated as safety issue: No ]

Enrollment: 610
Study Start Date: September 2009
Study Completion Date: February 2013
Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
80+ year olds
All 80+ year old that had had an ICU stay of >=24 hrs.

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   80 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

80+ year old admitted to ICU

Criteria

Inclusion Criteria:

  • minimum stay in the ICU of 24 hrs
  • patient is >=80 years old
  • patient is a resident of Canada and has a permanent address in this country
  • patient has an eligible family caregiver who has visited the patient at least once within 96 hours of the current ICU admission

Exclusion Criteria:

  • family caregiver is <= 18
  • family caregiver is paid to do so
  • family caregivers that do not speak English or French
  • previously enrolled
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01293708

Locations
Canada, Alberta
Foothills Hospital
Calgary, Alberta, Canada, T2N 2T9
University of Alberta Hospital
Calgary, Alberta, Canada, T6G 2B7
Peter Lougheed Hospital
Calgary, Alberta, Canada, T1Y 6J4
Royal Alexandra Hospital
Edmonton, Alberta, Canada, T5H 1A8
Grey Nuns Community Hospital
Edmonton, Alberta, Canada, T6T 0Z0
Canada, British Columbia
Royal Columbian Hospital
New Westminster, British Columbia, Canada, V3L 3W4
Surrey Memorial Hospital
Surrey, British Columbia, Canada, V3W
Royal Jubilee Hospital
Vancouver, British Columbia, Canada, V8R 1J8
Victoria General Hospital
Vancouver, British Columbia, Canada, V8Z 6R5
St.Paul's Hospital
Vancouver, British Columbia, Canada, V6Z 1Y6
Canada, Manitoba
Winnipeg Health Sciences Center
Winnipeg, Manitoba, Canada, R3A 1R9
St. Boniface Hospital
Winnipeg, Manitoba, Canada, R2H 2A6
Canada, Ontario
St. Joseph's Healthcare
Hamilton, Ontario, Canada, L8N 4A6
Kingston General Hospital
Kingston, Ontario, Canada, K7L 2V7
Ottawa Hospital
Ottawa, Ontario, Canada, K1Y 4E9
Mount Sinai
Toronto, Ontario, Canada, M5G 1X5
Sunnybrook Health Sciences
Toronto, Ontario, Canada, M4N 3M5
Toronto General Hospital
Toronto, Ontario, Canada, M5G 2C4
St. Michaels Hospital
Toronto, Ontario, Canada, M5B 1W8
Canada, Quebec
Hospital Maisonneuve-Rosemont
Montreal, Quebec, Canada, H1T 2M4
Hospital de Sacre-Coeur
Montreal, Quebec, Canada, H4J 1C5
Canada, Saskatchewan
Royal University Hospital
Saskatoon, Saskatchewan, Canada, S7N 0W8
Canada
Departement d'Anesthesie
Quebec, Canada, G1J 1Z4
Hospital Laval
Quebec, Canada, G1V 4G5
Sponsors and Collaborators
Daren K. Heyland
Canadian Institutes of Health Research (CIHR)
Investigators
Study Chair: Daren Heyland, MD Clinical Evaluation Research Unit,, Kingston General Hospital
  More Information

No publications provided

Responsible Party: Daren K. Heyland, Dr. Daren Heyland, Clinical Evaluation Research Unit at Kingston General Hospital
ClinicalTrials.gov Identifier: NCT01293708     History of Changes
Other Study ID Numbers: R80
Study First Received: February 10, 2011
Last Updated: February 19, 2013
Health Authority: Canada: Queen's University Health Sciences and Affliated Teaching Hospitals Research Ethics

Keywords provided by Clinical Evaluation Research Unit at Kingston General Hospital:
Octogenarians
HRQOL
mortality
prospective observational
Elderly

Additional relevant MeSH terms:
Critical Illness
Disease Attributes
Pathologic Processes

ClinicalTrials.gov processed this record on August 27, 2014